# L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

> **NCT06426147** · NA · RECRUITING · sponsor: **Barcelona Institute for Global Health** · enrollment: 2200 (estimated)

## Conditions studied

- Infectious Disease
- Infections
- Child, Only

## Interventions

- **DIETARY_SUPPLEMENT:** L-citrulline
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06426147
- **Lead sponsor:** Barcelona Institute for Global Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-08
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06426147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06426147, "L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06426147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*